A decade of spore-forming bacterial infections among european injecting drug users: Pronounced regional variation

American Journal of Public Health

Volumn 102, Issue 1, 2012, Pages 122-125

  Hope, Vivian D ^a   Palmateer, Norah ^b   Wiessing, Lucas ^c   Marongiu, Andrea ^a   White, Joanne ^a   Ncube, Fortune ^a   Goldberg, David ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BOTULISM; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM INFECTION; CLOSTRIDIUM TETANI; DRUG USE; EUROPE; HUMAN; IRELAND; NORWAY; STATISTICS; SUBSTANCE ABUSE; TETANUS; UNITED KINGDOM;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL INFECTIONS; BOTULISM; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM TETANI; DRUG USERS; EUROPE; GREAT BRITAIN; HUMANS; IRELAND; NORWAY; SUBSTANCE ABUSE, INTRAVENOUS; TETANUS;

EID: 84857261610     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300314     Document Type: Article

References (33)

1. Ramsay CN, Stirling A, Smith J, et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill. 2010;15(2):pii=19465.
2. Jones JA, Salmon JE, Djuretic T, et al. An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol. 2002;51(11): 978-984. (Pubitemid 35283742)
3. McGuigan CC, Penrice GM, Gruer L, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol. 2002;51(11):971-977. (Pubitemid 35283741)
4. Brett MM, Hood J, Brazier JS, Duerden BI, Hahne SJ. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005;133(4):575-582. (Pubitemid 41015547)
5. Health Protection Agency, Health Protection Scotland, Public Health Wales, Communicable Disease Surveillance Centre Northern Ireland, and the Centre for Research on Drugs and Health Behaviour. Shooting up: infections among injecting drug users in the United Kingdom 2009. November 2010. Available at: www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/InjectingDrugUsers/ GeneralInformation/idu-ShootingUp. Accessed April 19, 2011.
6. Hahne SJM, White JM, Brett M, et al. Tetanus emerges in injecting drug users in the UK [letter]. Emerg Infect Dis. 2006;12(4):709-710. Available at: www.cdc.gov/ncidod/EID/vol12no04/05-0599.htm. Accessed April 19, 2011.
7. Serious Organised Crime Agency. The United Kingdom Threat Assessment of Organised Crime 2009/10. Available at: www.soca.gov.uk/about-soca/library. Accessed April 19, 2011.
8. World Drug Report 2009. Vienna, Austria: United Nations Office on Drugs and Crime; 2009:44.
9. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). About EMCDDA. Available at: www.emcdda.europa.eu/about. Accessed April 19, 2011.
10. EMCDDA. Reitox network. Available at: www.emcdda.europa.eu/about/ partners/reitox-network. Accessed April 19, 2011.
11. EMCDDA. Drug-related infectious diseases. Available at: www.emcdda.europa.eu/themes/key-indicators/drid. Accessed April 19, 2011.
12. Alpers K, van Treeck U, Frank C. Outbreak of wound botulism in injecting drug users in Germany, October-December 2005. Euro Surveill. 2005;10(12): E051215.4.
13. Scheibe F, Hug B, Rossi M. Wundbotulismus nach Drogeninjektion [Wound botulism after drug injection]. Dtsch Med Wochenschr. 2002;127(5): 199-202.
14. Schroeter M, Alpers K, Van Treeck U, et al. Outbreak of wound botulism in injecting drug users. Epidemiol Infect. 2009;137(11):1602-1608.
15. Radun D, Bernard H, Altmann M, et al. Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Euro Surveill. 2010; 15(2):pii=19464.
16. Robert Koch-Institut. Kutaner Milzbrand nach intravenösem Heroinabusus. Epidemiologisches Bulletin, 2010. Available at: www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2010/02/Art-02.html. Accessed April 19, 2011.
17. Bernard H, Faber M, Grunow R, et al. Drogenkonsum: Bacillus anthracis in heroin? Dtsch Arztebl. 2010; 107(17):A-807/B-703/C-691. Available at: www.aerzteblatt.de/v4/archiv/artikel.asp?id=74552. Accessed April 19, 2011.
18. Mullen L, Barry J, Igoe D, Keenan E, Ward M, Murray K. Unexplained illness among injecting drug users in Dublin: a case-control study. J Epidemiol Community Health. 2002;56(8):575-576. (Pubitemid 34791472)
19. Botulism in injecting drug users. EpiInsight. 2002;3(6). Available at: www.hpsc.ie/hpsc/EPI-Insight/Volume32002/File, 661, en.PDF. Accessed April 19, 2011.
20. Barry J, Ward M, Cotter S, et al. Botulism in injecting drug users, Dublin, Ireland, November-December 2008. Euro Surveill. 2009; 14(1):pii=19082.
21. Vermeer-de Bondt P, Vos LP. Tetanus in an injecting drug user in the Netherlands: single case so far. Euro Surveill. 2004; 8(19):pii=2458.
22. Rundervoort RS, van der Ven AJ, Vermeulen C, van Oostenbrugge RJ. The clinical diagnosis "wound botulism" in an injecting drug addict [in Dutch]. Ned Tijdschr Geneeskd. 2003;147:124-127.
23. Blystad H, Hoel T, Høiby EA, Nilsen O. Infections among injecting drug users in Norway, 1997-2000. Euro Surveill. 2001; 5(1):pii=1829.
24. EMCDDA Statistical Bulletin 2011; Table PDU-102: prevalence of problem drug use at national level, part (ii): injecting drug use. Available at: www.emcdda.europa.eu/stats11/pdutab102b. Accessed July 15, 2011.
25. Annual Epidemiological Report on Communicable Diseases in Europe 2009. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2009.
26. Trends in Injecting Drug Use in Europe. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; June 2010. EMCDDA Selected Issue Report.
27. Health Protection Scotland. Scottish anthrax outbreak declared over. HPS Weekly Report. 2011; 3(2):11.
28. Anthrax in an injecting drug user in Kent-update. Health Protection Agency press release, November 3, 2010. Available at: www.hpa.org.uk/ ProductsServices/LocalServices/SouthEast/SouthEastPressReleases/Kent/ seast101103anthraxupdate. Accessed April 19, 2011.
29. European Centre of Disease Prevention and Control (ECDC). Epidemiological updates: anthrax. Available at: http://ecdc.europa.eu/en/healthtopics/anthrax/ whats-new/Pages/epidemiological-updates.aspx. Accessed April 19, 2011.
30. European Centre of Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Joint ECDC and EMCDDA threat assessment: anthrax outbreak among drug users, UK and Germany; update: 11 February 2010. Available at: http://ecdc.europa.eu/en/activities/sciadvice/ Documents/2010-02-11-TA-anthrax-IDU-ECDC-EMCDDA.pdf. Accessed April 19, 2011.
31. Keim P, Price LB, Klevytska AM, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol. 2000;182(10):2928-2936. (Pubitemid 30246926)
32. Van Ert MN, Easterday WR, Huynh LY, et al. Global genetic population structure of Bacillus anthracis. PLoS ONE. 2007;2(5):e461.
33. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89-96.